Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 511 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1
Jianming Xu,Ken Kato, Richard Hubner,Sook Ryun Park,Takashi Kojima,Ryu Ishihara,Lucjan Wyrwicz,Eric Van Cutsem,Paula Jimenez-Fonseca, Hongqian Wu, Lei Wang, Sebastian Yan, Jingwen Shi, Alysha Kadva, Harry H. Yoon
Advances in Therapyno. 5 (2025): 2269-2284
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 511

#Citation: 15153

H-Index: 60

G-Index: 107

Sociability: 7

Diversity: 4

Activity: 175

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn